ketotifen has been researched along with Prostatic Neoplasms in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neuroendocrine prostate cancer (NEPC), a highly aggressive subtype of prostate cancer displaying resistance to hormone therapy, presents a poor prognosis and limited therapeutic options." | 1.91 | Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway. ( Chen, L; Ji, Y; Li, A; Liu, B; Shen, K; Su, R; Wang, Q; Xue, W; Zhang, W; Zhu, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y | 1 |
| Liu, B | 1 |
| Chen, L | 1 |
| Li, A | 1 |
| Shen, K | 1 |
| Su, R | 1 |
| Zhang, W | 1 |
| Zhu, Y | 1 |
| Wang, Q | 1 |
| Xue, W | 1 |
1 other study available for ketotifen and Prostatic Neoplasms
| Article | Year |
|---|---|
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway.
Topics: Animals; Cell Line, Tumor; Drug Repositioning; Humans; Interleukin-6; Ketotifen; Male; Mice; Prostat | 2023 |